ロード中...
Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer
BACKGROUND: Goserelin plus aromatase inhibitors (AI) have already been used in male advanced breast cancer, but the cases that fulvestrantin male breast cancer are rare. CASE PRESENTATION: Here we report a case of long-term (3 years) response to Goserelin plus continuing endocrine treatments given f...
保存先:
| 出版年: | World J Surg Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4326472/ https://ncbi.nlm.nih.gov/pubmed/25539790 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-12-393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|